. Studies in lab animals show the drug doesn't lead creatures to seek more of it, as they sometimes do with ketamine, says Allergan Vice President Armin Szegedi. Allergan's medicine is an IV drug, but the company is developing an oral drug. For its suicide study, Allergan is working hard to enroll veterans